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AntioxidantAbstract In the present study, we investigated the hepatoprotective potential of Parinari
curatellifolia Planch (Chrysobalanaceae) in experimental rats in order to ascertain the validity of
folkloric claims of its effectiveness in the treatment of hepatic-related disorders. Flavonoid extract
of P. curatellifolia seed, PCF (10-, 20- or 30 mg/kg body weight) or silymarin (25 mg/kg), dissolved
in corn oil, was administered by gavage to experimental animals once daily for 14 consecutive days
before liver damage was chemically induced through the administration of acetaminophen (2 g/kg
p.o.) on the 14th day. Hepatoprotection was assessed by analyzing liver homogenate and serum for
markers of hepatotoxicity – alanine aminotransferase (ALT), aspartate aminotransferase (AST), c-
glutamyl transferase (GGT) and lactate dehydrogenase (LDH) activities as well as prothrombin
time (PT). Evaluation of biochemical indices of oxidative stress – level of lipid peroxides (LPO),
activities of superoxide dismutase (SOD) and catalase, along with histological assessment of hepatic
tissue sections were also carried out. Results revealed that all doses of PCF signiﬁcantly (P< 0.001)
and dose dependently prevented acetaminophen-induced increase in serum activities of hepatic
enzymes (ALT, AST, GGT, LDH) and PT. Furthermore, PCF (10- and 20 mg/kg) signiﬁcantly
(P< 0.001) reduced lipid peroxidation in liver tissue and restored the activities of the antioxidant
enzymes SOD and catalase toward normal levels. Histopathology of the liver tissue showed that
PCF mitigated the toxicant-induced hepatocellular necrosis, reduced inﬂammatory cell inﬁltration
and enhanced hepatocyte regeneration. The results indicated that P. curatellifolia ﬂavonoids dem-
onstrated remarkable hepatoprotective activity in acute liver injury caused by acetaminophen.
ª 2014 Production and hosting by Elsevier B.V. on behalf of King Saud University.1. Introduction
Drug-induced hepatotoxicity is a common cause of liver injury
and accounts for approximately half of the cases of acute liver
failure while mimicking all forms of acute and chronic liver
diseases (Kaplowitz, 2004). Many prescription drugs currently
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which is becoming a serious health challenge since the liver is
the major site of drug metabolism. Acetaminophen (paraceta-
mol, N-acetyl-p-aminophenol) is a widely used over-the
counter analgesic and antipyretic drug with only weak antiin-
ﬂammatory property (Hinson et al., 2010). Acetaminophen
could cause potentially fatal centrilobular hepatic necrosis.
This occurs at high doses after its conversion by drug
metabolizing enzymes to a reactive metabolite, N-acetyl-p-
benzoquinone imine (NAPQI) that covalently binds to pro-
teins. At toxic doses, the metabolite suppresses the antioxidant
defense system and the amount of covalent binding correlates
with the relative hepatotoxicity (Jollow, 1973). Acetamino-
phen-induced liver injury is now a viable model of hepatotox-
icity popularly employed by clinical researchers to investigate
the beneﬁcial effects of drugs (Olaleye et al., 2010a, 2010b;
Pattanayak et al., 2011).
Finding sustainable therapeutic approach to minimizing
liver damage is important owing to the prevalence of this con-
dition. Medicinal plants used in the folkloric management of
liver-related diseases or diseases related to other organs could
be considered an alternative therapeutic approach (Salama
et al., 2013). The use of herbal and dietary supplements in dis-
ease management dates back to thousands of years (Schuppan
et al., 1999). The therapeutic value of medicinal plants is lar-
gely dependent on the constituent antioxidant phytochemicals,
notably the phenolics. This stems from the role of oxidative
stress in the etiology or progression of various diseases includ-
ing hepatic-related ones. Flavonoids constitute a large subset
and one of the most ubiquitous groups of plant phenolics
(De Groot and Raven, 1998). They are the major active nutra-
ceutical ingredients in plants (Tapas et al., 2008). Apart from
their antioxidant property, ﬂavonoids have been recognized
to possess antiinﬂammatory, antiallergic, hepatoprotective,
antithrombotic, antiviral, and anticarcinogenic activities
(Tapas et al., 2008). Silymarin, a standardized ﬂavonoid
extract from the seed of Silybum marianum, has been found
to be highly effective as a hepatoprotective agent and is now
widely used as a reference drug in hepatoprotective assess-
ments (Gupta et al., 2011; Salama et al., 2013).
The seeds of Parinari curatellifolia, commonly called
Mobola Plum, are widely employed in traditional medicine
for the management of various diseases including hypertension
(Olaleye et al., 2010a, 2010b), diabetes and liver-related ill-
nesses (Ogbonnia et al., 2011). Phytochemicals in the seed
include polyphenols, glycosides, alkaloids and anthraquinones
(Ogbonnia et al., 2008) but none of these has been speciﬁcally
correlated with hepatoprotection. Bearing in mind the role of
oxidative stress in both hepatic and non-hepatic diseases, we
presumed that the therapeutic efﬁcacy of P. curatellifolia could
be related to its antioxidant components. Since there is paucity
of information in this regard, the present study was aimed at
determining the possible effect of the ﬂavonoid extract of
P. curatellifolia seeds on acetaminophen-induced liver injury.2. Materials and methods
2.1. Chemicals
Thiobarbituric acid (TBA), malonaldehyde bis-(dimethyl ace-
tal) (MDA), Epinephrine, 50,50-Dithiobis-(2-nitrobenzoic acid)(DTNB) and hydrogen peroxide were purchased from Sigma
Chem., Co. (London, UK). c-glutamyl transferase (GGT),
alanine aminotransferase (ALT), aspartate aminotransferase
(AST), lactate dehydrogenase and total protein kits were
obtained from Randox Laboratories, UK. All other chemicals
were of analytical grade and were obtained from British Drug
Houses, (Poole, UK). The water used was glass distilled.
2.2. Plant material and preparation of crude extract
The seeds of P. curatellifolia were purchased at Oja-Oba in
Akure, Nigeria, in the month of February, 2013. Botanical
identiﬁcation and authentication were carried out at the her-
barium of the Forestry Research Institute of Nigeria (FRIN),
Ibadan, Nigeria. The seeds were air dried, pulverized and
stored in air-tight containers. The crude extraction of the seeds
was carried out with 80% methanol (Komolafe et al., 2013)
using a Soxhlet apparatus. The solvent was evaporated to dry-
ness and the dried methanolic extract (ME) was stored in an
airtight bottle at 4 C until needed.
2.3. Preparation of ﬂavonoid extract
A portion (3 g) of ME was dissolved in 20 ml of 1% H2SO4 in
a standard ﬂask and was hydrolyzed by heating on a water
bath for 30 min. The resulting mixture was placed on ice for
15 min to allow for the precipitation of the ﬂavonoid aglycone.
The cooled solution was ﬁltered and the solid on the ﬁlter
(ﬂavonoid aglycone mixture) was dissolved in 50 ml of warm
95% ethanol at 50 C. The resulting solution was re-ﬁltered
into a 100 ml volumetric ﬂask which was made up to mark
with 95% ethanol. The ﬁltrate ﬁnally collected was concen-
trated to dryness using a rotary evaporator (El-Olemy et al.,
1994). A calculated mass of the dried extract was dissolved
in an appropriate volume of corn oil to prepare various
concentrations which were administered to experimental
animals by oral gavage.
2.4. Animals
Adult male rats (Wistar strain) weighing 180–220 g, obtained
from a private breeder and housed in the primate colony of
the Department of Biochemistry, Federal University of Tech-
nology, Akure, Nigeria were used for this study. The animals
were kept in wire mesh cages under controlled light cycle
(12 h light/12 h dark), fed with commercial rat chow (Vital
Feeds Nigeria Limited) ad libitum, and liberally supplied with
water. All animal experiments were conducted according to the
guidelines of National Institute of Health (NIH publication
85-23, 1985) for laboratory animal care and use.
2.5. Experimental design
Age-matched rats were divided into nine groups (n= 6) and
treated as follows:
 Group I (Control) Corn oil (1 ml/kg).
 Group II Corn oil (1 ml/kg) + 2 g/kg Acetaminophen
(ACE).
 Group III 10 mg/kg P. curatellifolia ﬂavonoids (PCF) +
2 g/kg ACE.
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 Group V 30 mg/kg PCF + 2 g/kg ACE.
 Group VI 25 mg/kg silymarin (SIL) + 2 g/kg ACE.
 Group VII 10 mg/kg PCF only.
 Group VIII 20 mg/kg PCF only.
 Group IX 30 mg/kg PCF only.
Corn oil (1 ml/kg), silymarin (25 mg/kg) or PCF (10-, 20- or
30 mg/kg) were administered by gavage to healthy experimen-
tal rats once daily for 14 consecutive days and thereafter, rats
were challenged with a single oral dose of acetaminophen (2 g/
kg) on the 14th day. Animals were sacriﬁced under mild ether
anesthesia 24 h after ACE administration. Blood was collected
by cardiac puncture and the liver tissues dissected out for bio-
chemical and histological evaluation.
2.6. Assessment of hepatoprotective activity
The collected blood was allowed to clot and serum was
obtained after centrifugation at 3000 rpm for 15 min. The
activities of AST, ALT, LDH and GGT were estimated in
serum using assay kits obtained from Randox Laboratories
Ltd., UK according to the instructions of the manufacturer.
2.6.1. Prothrombin time test
The prothrombin time test is based on the time required for a
ﬁbrin clot to form after the addition of Tissue Factor (tissue
thromboplastin), phospholipid and calcium to decalciﬁed,
platelet poor plasma. The assay was carried out using the assay
kit provided by Quimica Clinica Aplicada, S.A., Spain accord-
ing to the manufacturer’s instruction (Hills and Ingram, 1973).
2.7. Assessment of hepatic antioxidant status
Excised livers were rinsed in 1.15% KCl and homogenized in
aqueous Tris–HCl buffer (50 mM, pH 7.4). Homogenates were
centrifuged at 10,000g for 20 min at 4 C to obtain the super-
natant fractions which were used for analyses.
2.7.1. Assessment of hepatic lipid peroxidation
Lipid peroxidation was determined by measuring the forma-
tion of thiobarbituric acid reactive substances (TBARS)
(Ohkawa et al., 1979).
2.7.2. Determination of superoxide dismutase (SOD) activity
The method of Misra and Fridovich (1972) was employed in
determining the activity proﬁle of SOD in the homogenates.
Brieﬂy, an aliquot of the diluted sample was added to 2.5 ml
of 0.05 M carbonate buffer (pH 10.2) to equilibrate in the spec-
trophotometer. The reaction was started by the addition of
0.3 ml of freshly prepared 0.3 mM adrenaline to the mixture
which was quickly mixed by inversion. The reference cuvette
contained 2.5 ml of buffer, 0.3 ml of substrate (adrenaline) and
0.2 ml of water. The increase in absorbance at 480 nm was mon-
itored every 30 s for 150 s. 1 unit of SOD activity was deﬁned as
the amount of SOD necessary to cause 50% inhibition of the oxi-
dation of adrenaline to adrenochrome during 1 min.
2.7.3. Determination of catalase activity
Catalase activity was determined by following the decomposi-
tion of H2O2 according to the method of Sinha (1971). Analiquot (1 ml) of properly diluted enzyme preparation was
rapidly mixed with an assay mixture containing 4 ml of
H2O2 (800 lmol) solution and 5 ml of 0.1 M phosphate buffer
(pH 7.0) in a conical ﬂask by a gentle swirling motion. The
reaction was run at room temperature. A 1 ml portion of the
reaction mixture was withdrawn and blown into 2 ml dichro-
mate/acetic acid reagent at 60 s intervals. The H2O2 content
of the withdrawn sample was determined by taking the absor-
bance at 570 nm. Catalase activity was expressed as lmol
H2O2 consumed/min/mg protein.
2.8. Histopathology
Representative liver tissue of each group was excised, trimmed
of fat and other connective tissues and prepared for histologi-
cal studies. The tissues were ﬁxed in 10% phosphate buffered
neutral formalin, dehydrated in graded (50–100%) alcohol
and embedded in parafﬁn. Thin sections (4–5 lm) were cut
and stained with hematoxylin and eosin (H & E) stain for
photomicroscopic assessment.
2.9. Statistical analysis
All values are expressed as mean ± SD of six animals. Statis-
tical evaluation was done using One Way Analysis of Variance
(ANOVA) followed by the Newman–Keuls comparison of
means. The signiﬁcance level was set at p< 0.05.
3. Results
3.1. Serum markers of hepatotoxicity
Toxicity arising from acetaminophen-intoxication was
manifested in rats as observed in the signiﬁcant elevation
(P< 0.001) in serum activities of GGT (195%), ALT
(139%), AST (107%) and LDH (141%) compared to the con-
trol (Table 1). Hepatoprotection by PCF (10-, 20- and 30 mg/
kg) was demonstrated by the respective signiﬁcant decreases in
serum activities of enzymes: GGT (45%, 50% and 58%); ALT
(47%, 56% and 52%); AST (37%, 43% and 49%); LDH
(27%, 38% and 40%) compared to the ACE-induced group
(P< 0.001). The observed effects of PCF (30 mg/kg) which
demonstrated the best protection were almost comparable to
those of the standard hepatoprotective drug, silymarin. PCF
alone produced a signiﬁcant decrease in ALT (10, 20, 30 mg/
kg; P< 0.001) and LDH (20, 30 mg/kg; P< 0.01) but caused
no change in other markers when compared to the control.
3.2. Prothrombin time and hepatic antioxidant status
Serum prothrombin formation time and extent of hepatic
membrane lipid peroxidation are shown in Fig. 1. Hepatic
injury induced by ACE caused signiﬁcant increases
(P< 0.001) in both the time for the formation of the clotting
factors in the blood and in the extent of lipid peroxidation in
rat hepatocytes. Signiﬁcant inhibition of these effects was
observed in PCF-treated rats. A >200% increase in MDA
level, an index of membrane lipid peroxidation, was recorded
in the ACE group. This was reduced in PCF (10- and 20 mg/
kg) groups by 32% and 37% respectively (P< 0.001). ACE
(2 g/kg) signiﬁcantly reduced hepatic activities of SOD (69%,
Table 1 Effects of Parinari curatellifolia ﬂavonoids (PCF) on serum markers of acetaminophen-intoxicated rats.
Treatment GGT (U/I) ALT (U/I) AST (U/I) LDH (U/I)
Control 3.26 ± 0.2 24.80 ± 1.4 40.20 ± 7.6 220.1 ± 3.0
ACE 9.61 ± 0.6*** 59.21 ± 1.2*** 83.21 ± 9.7*** 531.0 ± 4.2***
ACE+ PCF (10 mg/kg) 5.33 ± 0.7c 31.44 ± 1.1c 52.20 ± 7.7c 385.3 ± 7.2c
ACE+ PCF (20 mg/kg) 4.89 ± 0.6c 26.24 ± 1.0c 47.62 ± 6.5c 327.0 ± 3.3c
ACE+ PCF (30 mg/kg) 4.06 ± 0.5c 28.40 ± 2.2c 41.65 ± 6.1c 317.1 ± 3.0c
ACE+ SIL (25 mg/kg) 2.22 ± 0.4c 21.81 ± 0.9c 39.62 ± 6.1c 275.2 ± 3.2c
PCF (10 mg/kg) 3.08 ± 0.5 20.32 ± 1.3*** 35.64 ± 8.0 229.4 ± 4.9**
PCF (20 mg/kg) 2.92 ± 0.4 18.01 ± 1.3*** 34.86 ± 5.9 210.5 ± 1.8**
PCF (30 mg/kg) 2.35 ± 0.8* 20.68 ± 1.3*** 32.20 ± 3.9 213.2 ± 1.9**
Values are expressed as mean ± SD (n= 6). PCF, P. curatellifolia ﬂavonoids; GGT, gamma glutamyl transpeptidase; ALT, alanine amino-
transferase; AST, aspartate aminotransferase; LDH, lactate dehydrogenase.
P values: **<0.01, ***<0.001 compared with the normal control group I; b<0.01, c<0.001 compared with the ACT-induced group II.
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Figure 1 Effects of P. curatellifolia ﬂavonoids on serum prothrombin time (A) and hepatocyte membrane peroxidation (B) in
acetaminophen-intoxicated rats. Values are expressed as mean ± SD (n= 6). CrnO, corn oil; PCF, P. curatellifolia ﬂavonoids; ACE,
acetaminophen, SLM, silimarin. P values: **<0.01, ***<0.001 compared with the normal control group I; b<0.01, c<0.001 compared
with the ACE-induced group II.
Protective effects of Parinari curatellifolia ﬂavonoids 489P< 0.001) and CAT (64%, P< 0.001) when compared with
the control (Fig. 2). The protective effect of PCF on antioxi-
dant enzymes was reﬂected in the signiﬁcant increases, at all
doses employed, in the activities of SOD and CAT compared
with values obtained in the induced, untreated animals. The
observed effects of PCF were dose-dependent and the highest
effective concentration (30 mg/kg) was almost equipotent with
the reference drug, silymarin with regard to % increase in SOD
(185, P< 0.001 vs. 205, P< 0.001) and CAT (72, P< 0.01
vs. 83, P< 0.001) respectively.
3.3. Histopathology
The hepatoprotective effect of PCF was conﬁrmed by
histological studies of liver sections (Fig. 3) which support
the results obtained from serum enzyme assays. Normal
control rats (A) showed normal hepatic architecture with
no evidence of pathological changes whereas liver sections
of the ACE-induced group (B) showed total loss of hepaticarchitecture with patterns of cell necrosis, inﬂammatory
collections and accumulation of fatty lobules providing
histopathological evidence of tissue injury in the ACE-trea-
ted group. The pretreated animals showed noticeable protec-
tion from acetaminophen as evident from the improved
histologic indices. The histological architecture of liver sec-
tions of PCF (10 mg/kg)-treated rats (C) showed a more
or less normal lobular pattern with a mild edematous
change in the hepatic tissue. The 20 mg/kg PCF group (D)
showed patterns of regeneration of hepatocytes around the
central vein while the group treated with 30 mg/kg PCF
extract (E) only showed mild hepatocyte degeneration. The
liver architecture of E was comparable to the group pre-
treated with the standard drug, silymarin (F) which showed
less disarrangement of hepatocytes, indicating marked
regeneration activity with an almost near normal liver
architecture. The liver of non-induced animals treated with
PCF (10, 20 and 30 mg/kg) only (G–I) showed normal
histological features.
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Figure 2 Effects of P. curatellifolia ﬂavonoids on superoxide dismutase (A) and catalase (B) activities in the hepatocytes of
acetaminophen-intoxicated rats. Values are expressed as mean ± SD (n= 6). CrnO, corn oil; PCF, P. curatellifolia ﬂavonoids; ACE,
acetaminophen, SLM, silimarin. P values: **<0.01, ***<0.001 compared with the normal control group I; b< 0.01, c< 0.001 compared
with the ACE-induced group II.
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Figure 3 Photomicrographs of liver sections from rats treated with acetaminophen and the effect of PCF pretreatment. (A) Control
(vehicle) (B) ACE (C) 10 mg/kg PCF + ACE (D) 20 mg/kg PCF + ACE (E) 30 mg/kg PCF + ACE (F) 25 mg/kg SLM+ ACE (G)
10 mg/kg PCF alone (H) 20 mg/kg PCF alone (I) 30 mg/kg PCF.
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Plants have provided active ingredients of medicines for years
and are still sources of lead compounds in the development ofnew therapeutics (Newman, 2008). Some naturally occurring
substances have the potential to be hepatoprotective and there-
fore can be considered for use in the treatment of acute and
chronic liver diseases. The therapeutic efﬁcacy of ﬂavonoids
Protective effects of Parinari curatellifolia ﬂavonoids 491against numerous disease and pathological conditions has been
ﬁrmly established (Tapas et al., 2008). In the present study, the
hepatoprotective effects of P. curatellifolia ﬂavonoids (PCF)
on liver necrosis and damage induced by acute exposure to
ACE (2 g/kg) were assessed using biochemical and histological
parameters.
In line with previous ﬁndings on acetaminophen toxicity
(Olaleye et al., 2010a, 2010b; Pattanayak et al., 2011), we
observed signiﬁcant increases in the activities of serum markers
of hepatotoxicity; AST, ALT, GGT and LDH in acetamino-
phen-induced, untreated rats. Some of the most commonly
used biochemical markers of hepatocellular necrosis are serum
activity concentrations of the aminotransferases, AST and
ALT which are localized in the hepatocytes (Friedman et al.,
1996). Serum activities of these enzymes increase following cel-
lular membrane damage and consequent leakage to the extra-
cellular milieu. Highest levels occur in acute hepatocellular
injuries, such as drug-induced necrosis or acute viral hepatitis
leakage (Sturgill and Lambert, 1997). GGT, on the other hand,
is a microsomal enzyme abundant in hepatocytes and biliary
epithelial cells and involved in the transfer of c-glutamyl
groups from peptides to amino acids and the metabolism of
glutathione conjugates. Abnormally elevated serum activity,
as observed in the present study for ACE-induced animals, is
mainly attributed to hepatobiliary dysfunction (Friedman
et al., 1996). That levels of these markers tend toward normal
in animals treated with the ﬂavonoid extract suggest the hepa-
toprotective effects of the intervention. Parallel ﬁndings have
been previously reported (Tapas et al., 2008; Kumar, 2012).
In the same vein, elevation in serum LDH activity has been
correlated with liver damage following administration of
hepatotoxicant to rats (Ravikumar et al., 2010; Yakubu
et al., 2013). The signiﬁcantly decreased (P< 0.001) serum
LDH activity in PCF-treated animals signiﬁes improvement
over acetaminophen-dependent damage to the liver.
Prothrombin time (PT), an index of hepatic synthetic capacity,
has prognostic value in both acute and chronic liver injuries.
Worsening prolongation of the PT in the setting of acute hepa-
tocellular necrosis is associated with an increased risk of ful-
minant injury (Clark et al., 1973; Sturgill and Lambert,
1997). It could be established from the present study that
ACE-induced PT prolongation in rat serum was prevented
by PCF treatment. The observation that PCF alone did not
increase the serum levels of hepatic indices but instead caused
signiﬁcant reduction of serum ALT and AST, could suggest
the non toxicity of the ﬂavonoid extract by itself to the
hepatocytes (Olaleye et al., 2010a, 2010b).
The hepatoprotective effect of PCF was further conﬁrmed
by ﬁndings from the histological studies of liver sections.
The typical derangement in hepatic architecture observed in
ACE-treated rats (Hewawasam et al., 2003; Pattanayak
et al., 2011) was improved in animals pretreated with PCF in
a similar manner to silymarin-treated rats. The observed
close-to-normal lobular pattern with mild cellular necrosis
and lymphocyte inﬁltration as well as patterns of hepatocyte
regeneration in the liver sections of PCF-treated rats all point
to the protective effect of the ﬂavonoid extract. In the present
study, PCF exhibited a dose-dependent activity with an overall
optimum protective effect at the maximum dose of 30 mg/kg
comparable with the control and standard (silymarin-treated)
groups.Evidences support the generation of reactive oxygen species
during ACE hepatotoxicity and the fact that this plays a criti-
cal role in cell death (Jaeschke et al., 2003, 2010). Estimation of
lipid peroxide levels gives quantitative analysis of cellular
membrane damage resulting from oxidative stress. In the pres-
ent study, the induction of oxidative stress and the overwhelm-
ing of the antioxidant defense by ACE in rat hepatocytes
resulted in aggravated membrane lipid peroxidation as
observed in the elevated TBARS levels in liver homogenates.
Inferring from the reduced levels of TBARS in PCF-treated
rats, it can be argued that the ﬂavonoid extract promoted sig-
niﬁcant recovery of rat hepatocyte membrane integrity possi-
bly through its antioxidant activity. The consequent
oxidative stress arising from ACE toxicity could be responsible
for the signiﬁcant loss of SOD and catalase activities. These
endogenous antioxidant enzymes are responsible for the dis-
mutation of superoxide radicals to H2O2 and detoxiﬁcation
of H2O2 to water respectively thereby offering protection
against tissue damage. For instance, administration of encap-
sulated SOD has been reported to decrease the toxicity of acet-
aminophen in rat (James et al., 2003). As observed in the
present study and in line with previous reports (Donovan
et al., 1999; Manach et al., 2005), orally administered P. cura-
tellifolia ﬂavonoids were absorbed to biologically relevant con-
centrations in the hepatocytes of rats where they elicited the
recovery of the antioxidant enzyme status. Apart from their
direct antioxidant and free radical scavenging effects, ﬂavo-
noids are capable of upregulating the synthesis of antioxidant
enzymes (Li et al., 2006; Quinones et al., 2013). We can hypoth-
esize that P. curatellifolia ﬂavonoids, through its antioxidant
activity, prevented the overwhelming of the antioxidant
defense and the covalent binding of reactive intermediates of
ACE to critical proteins with the resultant reduction of acet-
aminophen-induced liver necrosis as evident in the biochemical
and histological results (Hinson et al., 2010).
In vivo, some ﬂavonoid metabolites exhibit prooxidative
tendencies which proceed via concentration-dependent stimu-
lation of hydrogen peroxide production (Metodiew et al.,
1999; Procha´zkova´ et al., 2011). Such prooxidative properties
do not necessarily indicate toxicity in its entirety but could
be associated with a cell signaling mechanism by which ﬂavo-
noids contribute to the co-ordination of cell functions
(Procha´zkova´ et al., 2011). In some instances, these effects
could be beneﬁcial and capable of causing overall cytoprotec-
tion, since levels of some antioxidant defenses and biotransfor-
mation enzymes might be elevated due to the mild degree of
oxidative stress ensuing (Halliwell, 2008). Going by the ﬁnd-
ings in the present study, the possibility of a prooxidative ten-
dency of PCF by itself, at higher concentrations in rats, cannot
be completely ignored. Such could account for the decreased
catalase activity and the attendant membrane lipid peroxida-
tion, especially at higher concentrations, in rats treated with
the ﬂavonoid extract alone. This observation, notwithstanding,
does not put the hepatoprotective effect of PCF in doubt going
by the array of results corroborating this property.5. Conclusion
Going by the present study, it could be concluded that
P. curatellifolia ﬂavonoids exhibited hepatoprotective activity.
492 M.T. Olaleye et al.Further research is ongoing in our laboratory to characterize
the speciﬁc ﬂavonoids involved as well as to ascertain their
individual contributions and exact mechanism(s) of action.
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